Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6245 | 1445 | 38.0 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
730 | 11996 | TUBULOGLOMERULAR FEEDBACK//SALT SENSITIVITY//AFFERENT ARTERIOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NORMAL PATHOL PHYSIOL | Address | 21 | 22% | 6% | 82 |
2 | NO DEFICIENCY | Author keyword | 7 | 67% | 0% | 6 |
3 | L NAME HYPERTENSION | Author keyword | 5 | 54% | 0% | 7 |
4 | ARTERIAL HYPERPLASIA | Author keyword | 4 | 75% | 0% | 3 |
5 | MENTHA CORDIFOLIA OPIZ | Author keyword | 4 | 75% | 0% | 3 |
6 | GLOMERULAR HAEMODYNAMICS | Author keyword | 3 | 57% | 0% | 4 |
7 | NITRIC OXIDE PHYSIOLOGY | Author keyword | 3 | 100% | 0% | 3 |
8 | MACULA DENSA | Author keyword | 3 | 14% | 1% | 20 |
9 | NITRIC OXIDE DEFICIENCY | Author keyword | 3 | 38% | 0% | 6 |
10 | NO DEFICIENT HYPERTENSION | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHRONIC INHIBITION | 29 | 34% | 5% | 71 |
2 | NO DEFICIENT HYPERTENSION | 27 | 76% | 1% | 19 |
3 | DEFICIENT HYPERTENSION | 26 | 80% | 1% | 16 |
4 | GLOMERULAR CAPILLARY PRESSURE | 20 | 49% | 2% | 30 |
5 | ARGININE METHYL ESTER | 15 | 16% | 6% | 88 |
6 | LONG TERM BLOCKADE | 15 | 38% | 2% | 30 |
7 | MICROPERFUSED RABBIT AFFERENT | 12 | 45% | 1% | 20 |
8 | SYNTHESIS INHIBITION | 11 | 28% | 2% | 33 |
9 | CHRONIC BLOCKADE | 9 | 30% | 2% | 26 |
10 | NORMAL RAT KIDNEY | 8 | 60% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of nitric oxide in the regulation of nephron transport | 2002 | 133 | 85 | 52% |
Nitric oxide in the kidney: functions and regulation of synthesis | 2006 | 75 | 103 | 61% |
Participation of Nitric Oxide in Different Models of Experimental Hypertension | 2008 | 56 | 87 | 49% |
Chronic nitric oxide inhibition model six years on | 1998 | 162 | 98 | 70% |
Biosynthesis and homeostatic roles of nitric oxide in the normal kidney | 1997 | 271 | 194 | 37% |
Regulation of Renal NaCl Transport by Nitric Oxide, Endothelin, and ATP: Clinical Implications | 2011 | 29 | 68 | 34% |
L-NAME in the cardiovascular system - nitric oxide synthase activator? | 2012 | 16 | 74 | 38% |
Role of nitric oxide in renal hemodynamics | 1999 | 50 | 85 | 86% |
The role of nitric oxide in the maintenance of vasoactive balance | 2007 | 29 | 61 | 43% |
Paradoxes of nitric oxide in the diabetic kidney | 2003 | 101 | 151 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NORMAL PATHOL PHYSIOL | 21 | 22% | 5.7% | 82 |
2 | EXCELLENCE EXAMINAT REGULATORY ROLE NITR OXID | 3 | 35% | 0.4% | 6 |
3 | MORPHOMETRY CARDIOVASC MORPHOL | 2 | 20% | 0.7% | 10 |
4 | GRP REIN HYPERTENS | 2 | 20% | 0.6% | 9 |
5 | EXCELLENCE CARDIOVASC | 2 | 13% | 0.9% | 13 |
6 | MORFOMETRIA MORFOL CARDIOVASC | 2 | 20% | 0.6% | 8 |
7 | U489 | 1 | 11% | 0.6% | 9 |
8 | INSERM U489 | 1 | 21% | 0.3% | 4 |
9 | PHYSIOL SL39 | 1 | 16% | 0.3% | 5 |
10 | HYPERTENS S | 1 | 23% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000247038 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
2 | 0.0000225139 | MEDULLIPIN//RENAL INTERSTITIAL HYDROSTATIC PRESSURE//RENAL MEDULLARY BLOOD FLOW |
3 | 0.0000180513 | TUBULOGLOMERULAR FEEDBACK//AFFERENT ARTERIOLE//RENAL AUTOREGULATION |
4 | 0.0000146777 | ENDOTHELIUM DEPENDENT CONTRACTIONS//ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR |
5 | 0.0000115429 | EDRF//NG NITRO L ARGININE//EDRF ENDOTHELIUM DERIVED RELAXING FACTOR |
6 | 0.0000115055 | GEORGE M OBRIEN KIDNEY UROL DIS//GEORGE OBRIEN KIDNEY UROL DIS//SERV 151 E |
7 | 0.0000079415 | REDUCED RENAL PERFUSION PRESSURE//PRESSURE ESCAPE//JR GRP 2 |
8 | 0.0000075631 | POLYASPARTOYL L ARGININE//BEIJING S HYDRONE PEPTIDES//CHAIR SEMEIOL MED METHODOL |
9 | 0.0000069052 | HYPERTENS RENAL EXCELLENCE//URINARY ANGIOTENSINOGEN//RECEPTOR SIGNAL TRANSDUCT |
10 | 0.0000065270 | UMR 6214//C3HEB FEJ//IFR CIRCULAT PARIS NORD |